# Official Website: Myriad Genetics

**Type:** source
**Status:** Useful
**Confidence:** Medium
**Source Type:** Official Website
**URL:** https://www.myriad.com/
**Publisher:** Myriad Genetics
**Accessed:** 2026-06-19
**Updated:** 2026-06-19

## Summary

Myriad Genetics's official website describes its clinical genetic and genomic testing portfolio across hereditary cancer risk, reproductive health, oncology, urology, and mental health pharmacogenomics.

## Useful Claims

- Myriad says it has partnered with the healthcare community for more than 30 years to advance genetics and tumor genomic profiling.
- The site organizes tests into five health areas: hereditary cancer risk, reproductive health, oncology, urology, and mental health.
- Hereditary cancer products are described as helping detect risk across multiple cancer types; the site references tests covering 11 hereditary cancers.
- Oncology offerings include germline and tumor genomic tests intended to support screening, treatment, and survivorship decisions.
- Reproductive-health products include carrier screening, prenatal chromosomal testing, and early fetal-sex determination.
- Urology products include Prolaris; the homepage highlights Prolaris + AI combining genomics with AI-driven digital pathology for active-surveillance management.
- Mental-health offerings use pharmacogenomics to inform antidepressant and related medication selection.
- The site claims one of the largest repositories of comparative variant data covering all ancestries.

## Reliability Notes

This is an official company source. It is useful for product categories, patient/provider positioning, and current menu structure, but test performance, market share, and clinical-outcome claims should be cross-checked with peer-reviewed publications, FDA or LDT documentation, and third-party coverage before being used as high-confidence evidence.

## Related Pages

- [Myriad Genetics](myriad-genetics.md)